ArticleBMJ open2017

Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour types.

Caroline Lonez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.